Volume 3, Issue 3, September 2022

View Volume 3, Issue 3, September 2022

Palmoplantar Pustular Psoriasis: An Update on Pathophysiology and Review of Treatment Options
New Trends in Pediatric Antihistamine Use
Morphea Through the Ages
Staying Ahead of Dupilumab-Associated Ocular Surface Disease
Poly-L-Lactic Acid for Global Facial Volumization
Dermatologic Immune-Related Adverse Events With Immune Checkpoint Inhibitors

Published: 2022-09-01

Articles

Palmoplantar pustular psoriasis: an update on pathophysiology and review of treatment options

Fiona Lovegrove, MD, PhD

8–11
- PDF (en)
- PDF (fr)
New trends in pediatric antihistamine use

Ashley O’Toole, MD, MHSc, FRCPC

13–16
- PDF (en)
- PDF (fr)
Morphea through the ages

Cathryn Sibbald, MD, FRCPC

18–24
- PDF (en)
- PDF (fr)
Staying ahead of dupilumab-associated ocular surface disease

Patricia-Ann Laughrea, MD, Mélanie Hébert, MD

26–34
- PDF (en)
- PDF (fr)
Poly-L-lactic acid for global facial volumization

Malika Ladha, MD, FRCPC

36–38
- PDF (en)
- PDF (fr)
Dermatologic immune-related adverse events with immune checkpoint inhibitors

Abdulhadi Jfri, MD, MSc, FRCPC

40–46
- PDF (en)
- PDF (fr)